Next Article in Journal
Maternal Exposure to Pyrethroid Insecticides during Pregnancy and Infant Development at 18 Months of Age
Previous Article in Journal
Indoor Temperatures in Patient Waiting Rooms in Eight Rural Primary Health Care Centers in Northern South Africa and the Related Potential Risks to Human Health and Wellbeing
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 14
Issue 1
10.3390/ijerph14010050
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China

by
Jie Chang
1,2,
Boyang Li
3,
Jingjing Li
4,5 and
Yang Sun
6,*
1
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China
2
Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710061, China
3
School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
4
Department of Behavior Science and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
5
Department of Epidemiology, School of Public Health, Wuhan University, Wuhan 430071, China
6
Department of Public Affairs and Management, School of Political Science and Public Administration, Wuhan University, 299 Bayi Road, Wuchang District, Wuhan 430072, China
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2017, 14(1), 50; https://doi.org/10.3390/ijerph14010050
Submission received: 10 December 2016 / Revised: 10 December 2016 / Accepted: 22 December 2016 / Published: 7 January 2017
(This article belongs to the Section Global Health)
Browse Figures
Versions Notes

Abstract

:
In contrast with most developed countries, mortality due to ischemic heart disease (IHD) continues to rise in China. We examined the effects of age, period, and cohort on IHD mortality in urban and rural populations from 1987 to 2013 to identify the drivers of this trend. Region-specific data on annual IHD mortality among adults aged 20 to 84 years and corresponding population statistics were collected. We then tested for age, period, and cohort effects using the Intrinsic Estimator approach. Our results indicated that IHD mortality in China increased significantly over the three decades studied. There was a log-linear increase in the age effect on IHD mortality as those aged 80–84 showed 277 and 161 times greater IHD mortality risk than those aged 20–24 in urban and rural populations, respectively. While there was an upward trend in the period effect in both populations, the influence of the cohort effect on mortality decreased over time for those born from 1904 to 1993. The age, period, and cohort effects on mortality in China were generally comparable between urban and rural populations. The results suggest that population aging is a major driver behind the rapid rise in IHD mortality. Increased exposure to air pollution may also have played a role in driving the period effect

1. Introduction

Ischemic heart disease (IHD) is a leading cause of morbidity and mortality worldwide [1,2,3] and is responsible for over 7 million deaths annually—or 13% of all-cause mortality [4,5]. Although a rising trend in IHD mortality rates has been observed since the beginning of the 20th century, this trend was found to have reversed in most industrialized countries after IHD mortality rates reached a peak by the 1970s owing to improvements in both treatment and prevention [1,6,7]. By contrast, mortality due to IHD continues to rise in many low- and middle- income countries [8,9,10,11].
Variation in mortality rates over time is strongly attributable to influences that vary by age, calendar period of death, and birth cohort [12]. Among these, the cohort effect has received relatively little attention [13]. However, the influence of different risk factors for IHD mortality can vary with both the age of exposed individuals and level of exposure over time [14]. Analyses based on the assumption that changes in mortality rates over time are equal across birth cohorts, depend on rates of change in period-specific risk exposure, or are independent of an individual’s year of birth, may lead to unreliable or even misleading conclusions. It is therefore necessary to analyze the influences of age, period, and cohort effects together to fully understand the drivers behind trends in IHD mortality over time.
China has experienced rapid economic growth and social change since the adoption of economic reforms from 1978 onwards, which has in turn resulted in substantial changes in lifestyle for the majority of the population. Like many other developing countries, China is confronting a double burden of disease as a result of the epidemiologic transition. Non-communicable diseases represent a major challenge, both adversely affecting population health and increasing the financial burden on China’s healthcare system [15]. Based on findings of the Global Burden of Disease Study 2015, the number of deaths attributable to IHD increased from 7648.4 thousand in 2005 to 8917.0 thousand 2015 [16]. Furthermore, IHD represented the second leading cause of years of life lost among the Chinese population in 2015 [16].
Age-period-cohort (APC) analysis can identify net age, period, and cohort effects from age-specific mortality data gathered over time. It has played a critical role in identifying risk factors underlying mortality from different causes in a macroscopic context. While previous analyses have estimated age, period, and cohort effects on IHD mortality in other countries and regions [17,18,19,20,21,22], Chinese data have been used to estimate the impact of population aging on coronary heart disease on the national level [23], predict future trends in prevalence and incidence of cardiovascular disease [24], and analyze the upward trend in coronary heart disease in Beijing City [25].
We sought to quantify the age, period, and cohort effects on secular trends in IHD mortality in urban and rural China by using national statistics over an extended period to inform long-term national IHD prevention strategies.

2. Methods

2.1. Data Sources

IHD cases were defined using the International Classification of Diseases (ICD) codes ICD-9 410.00–414.9 for data collected prior to 2002 and ICD-10 I20–I25 for data from 2002 onwards. Official national-level data on annual IHD mortality rates were extracted from the Chinese Health Statistical Annual Report (1987–2001) and the Chinese Health Statistics Yearbook (2003–2013). The mortality statistics obtained were based on events recorded by the Ministry of Health-Vital Registration (MOH-VR) System, which has been shown to provide a high degree of reliability. Corresponding information about urban and rural population by five-year age groups were derived from the third to the sixth National Population Census (1982, 1990, 2000 and 2010). Using these two data sources, we calculated age- and region-specific IHD mortality among those aged 20–84 for each five-year period between 1987 and 2013.
Data gathered from 1987 to 2013 were included in the full APC analysis and were tabulated to yield 13 five-year age groups from 20–24 to 80–84 years, six quinquennial time periods between 1987 and 2013 (1988, 1993, 1998, 2003, 2008, 2013), and 18 consecutive cohorts including those born in 1904–1908 and aged 80–84 years in 1988 to those born in 1989–1993 and aged 20–24 in 2013.
While data from individuals aged 0–19 was not analyzed owing to the extremely low incidence of IHD in this group, data from those aged 85 years and older were not included as this was an open-ended age group and mortality data were not available by five-year age brackets.

2.2. Statistical Analysis

Estimates of mortality rates were fitted using a basic APC model, which was initially operationalized as a linear regression equation:
Mij = Dij/Pij = μ + αi + βj + γk + εij
where Mij denotes the observed death rate for the ith age group for i = 1,…, a age groups in the jth time period for j = 1,…, p time periods of observed data, Dij denotes the number of deaths in the ijth group, and Pij denotes the estimated population size of the ijth group. Furthermore, μ denotes the model intercept or adjusted mean, αi denotes the ith row age effect or the coefficient for the ith age group, βj denotes the jth column period effect or the coefficient for the jth time period, γk denotes the coefficient for the kth cohort for k = 1,…, (a + p − 1) cohorts (with k = a − i + j), and εij denotes the random error term with the expectation that E(εij) = 0.
Each of the three time-dependent variables is a function of the other two, such that the independent effects are difficult to separate. This results in the “identification problem”, for which a number of solutions exist—each with their own set of limitations [26,27]. We therefore applied the intrinsic estimator (IE) method [28], which has recently been used in a similar context to study secular trends in disease incidence and cause-specific mortality [29] and is considered to achieve model identification with the fewest assumptions.
Statistical analyses were conducted using Stata 12.0 (StataCorp LP, College Station, TX, USA) using the “apc_ie” command. The outcome variable, IHD mortality, was log transformed and odds ratios were calculated for each model parameter to allow comparison of mortality risk. We fitted three one-factor models, two two-factor models, and a full three-factor model to analyze each possible combination of age, period, and cohort effects. The Akaike information criterion (AIC) and the Bayesian information criterion (BIC) were then used to evaluate goodness-of-fit for each model.
In addition, we conducted a sensitivity analysis based on data adjusted for the change in the ICD to examine whether the change from ICD-9 to ICD-10 has caused notable impact on our results and conclusions. We first quantified the impact of the ICD change by deriving adjusting factors for urban and rural populations (dividing the overall IHD morality rates of urban and rural population of 2003 by the rates of 2001, respectively). Then we deflated all the data collected prior to 2002 based on ICD-9 using the adjusting factors to generate an adjusted data set for modeling. The results of APC analysis with IE approach using the adjusted data are shown in the Supplementary Materials. The approach of adjustment has been used in previous APC studies for similar purpose [30].

3. Results

3.1. Descriptive Analysis

Figure 1 shows the overall secular trends in IHD mortality in urban and rural populations from 1987 to 2013. Mortality increased by approximately 2.5 and 5 times in urban and rural populations respectively over this period. Despite fluctuations, IHD mortality rates in urban areas were consistently higher than in rural rates in these years—although the gap narrowed towards the end of the period as mortality in the rural population increased rapidly from 2005 and converged with that in urban areas by 2013.
Age-specific IHD mortality rates by period are shown in Figure 2 for urban and rural populations. Overall IHD mortality rates increased with age following a log-linear trend such that IHD mortality risk among those aged 80–84 and 20–24 differed almost 1000-fold in both populations.
Period-specific IHD mortality rates by age group in urban and rural populations are shown in Figure 3. While mortality increased consistently among those aged 50–54 and 80–84 in rural areas, all other groups experienced fluctuating mortality risk over time without a discernible trend. Mortality risk was least stable among those aged less than 45 years—particularly in rural areas.
Figure 4 shows cohort-specific IHD mortality rates by age group. The influence of cohort on mortality differed by age group. While mortality among those aged 50–54 and 80–84 in rural areas was found to increase steadily with each successive cohort, there was no apparent trend in any other population group.

3.2. Statistical Analysis

Table 1 shows the results of each of the seven models fitted. The goodness-of-fit measures show that the full three-factor model accounting for age, period and cohort effects simultaneously provided the best prediction of IHD mortality rates over time.
Coefficients were then plotted to show the net effects of age, period, and cohort on overall IHD mortality trends, as shown in Figure 5. The corresponding results from the full APC model are displayed in Table 2. While the age effect most strongly influenced mortality rates, the period effect was relatively minor.
Age effect. The age effect increased over time in an approximately log-linear fashion in urban and rural populations. While this effect was stronger in the latter, particularly among individuals aged under 44 years, it was more pronounced among those over 44 in urban areas. Overall, the influence of age on mortality increased faster in the urban population.
Period effect. The influence of period effects increased in urban and rural populations throughout the study period. While the period effect was more pronounced during 1988–1998 in the urban population, period had a greater influence on mortality in the rural population from 2003 onwards. Overall the period effect followed a V-shaped trend during 1998–2008—although a continuous rising trend was seen in the rural population moderated from 2003 to 2008.
Cohort effect. The influence of cohort on mortality decreased over time in both urban and rural populations. There were three increases in the birth cohort effect in the rural population born from 1919–1923 to 1924–1928, 1959–1963 to 1964–1968, and 1979–1983 to 1984–1988. The cohort effect was generally weaker in urban population among individuals born from 1929–1933 onwards and its influence on mortality was found to decrease over time—although, notably, this trend moderated among those born from 1974–1988.

4. Discussion

According to the Report on Cardiovascular Diseases in China (2013), the average annual growth rate in IHD mortality from 2004 to 2012 was 5.05%—a trend which is expected to continue over the next decade. Although previous studies have applied APC analysis to investigate the decline in IHD mortality over recent decades in developed countries [17,18,19,20], studies to examine the influence of age, period, and cohort effects on secular trends in IHD mortality in China have been scarce. The current study can provide insight into possible population-level risk factors driving the rapid rise in IHD mortality, and signpost avenues for future studies or public health intervention strategies.
Our findings regarding age effects on IHD mortality in both the urban and rural populations are in line with those from previous studies conducted in other countries [17,19,22], which indicate that IHD mortality is highly age-dependent. Although aging is a non-modifiable risk factor for IHD, it is accompanied by declines in health and physical functioning, and, as such, is positively associated with modifiable risk factors such as elevated blood pressure, diabetes mellitus, and hypercholesterolemia [31].
Population aging in China has gathered pace owing to the sharp decline in fertility and rising life expectancy. The number of people aged 65 and over increased from 49.28 million (or 4.91% of the population) in 1982 to 88.27 million (7.10%) in 2000. By 2010, this number rose to 118.93 million (8.92%, and 10.6% in rural areas) [32,33]. One previous study concluded that population aging is the dominant driver behind the increase in IHD mortality and resulted in a 27% rise mortality in Beijing from 1990 to 2010 [34]. Another predicted that coronary heart disease mortality will be 64% higher (resulting in 3.4 million additional deaths) in the decade 2020–2029 than in 2000–2009 solely owing to population growth and aging [23]. Our findings, together with those of previous studies, highlight the extent to which population aging has exacerbated the IHD disease burden in China.
Although similar age-specific patterns in IHD mortality were identified in urban and rural populations, it is notable that the age effect increased faster in the urban population. Furthermore, while the age effect was stronger in the rural population aged under 45 years, this effect was reversed among those over 45 years. China has become one of the countries with the severest urban air pollution problem in recent years [35]. One study conducted in 74 leading Chinese cities concluded that PM2.5 (particle less than 2.5 mm in aerodynamic diameter) was associated with 35% of cardiovascular mortality in 2013, which accounted for 47% of all PM2.5 related death of that year [36]. While many leading cities in China have become highly air polluted regions, however, the concentration of main air pollutants was somewhat lower in rural areas. This fact might relate to the slight difference in the changing pattern of age effects between urban and rural populations.
There was a falling trend in the influence of the cohort effect on IHD mortality for both urban and rural populations from 1904 to 1993—as has also been reported in Spain, Hungary, and South Korea [17,19,22]. Moreover, a recent study investigating secular trends in breast cancer mortality in China, South Korea, Japan, and United States employing APC analysis found that all countries experienced a similar general decline in the cohort effect over time despite differences in mortality trends [37]. This phenomenon may highlight that the Chinese population has substantially benefited from improvements in nutrition, living conditions, and availability of healthcare through much of the last century—resulting in a weakening of the cohort effect.
This stands in contrast, however, with recent population-level rising exposure to other modifiable risk factors such as, diabetes, cholesterolemia, and obesity. This trend may have the potential to strengthen the cohort effect—a point of concern raised by Wang et al. in interpreting a recent APC analysis [37,38]. Nevertheless, this is still reasonable, given that the effects of increases in these risk factors might have been offset by other driving forces in the opposite direction. Besides the successive overall improvements in nutrition, living conditions, and healthcare across birth cohorts in China in the last century, recent declines in some important risk factors of IHD might also have played a role. For example, while rates of smoking, a major modifiable lifestyle risk factor for IHD, remain relatively high, the recent decrease in smoking prevalence among Chinese men in most age groups, especially in younger age groups [39,40], may also have contributed to the decline in cohort effects on IHD mortality. However, caution should also be taken when interpreting the strength of the cohort effect in younger generations as their later-life risk of IHD could not be compared with that of previous generations. Furthermore, cumulative lifetime exposure to these other lifestyle risk factors may not yet be sufficient among younger generations to have influenced IHD mortality rates.
Period effects primarily result from changes in environmental determinants of mortality over time, which influence all age groups equally. Despite minor differences, our results showed that the period effect strengthened over time in both urban and rural populations. Although the magnitude of the age and cohort effects were comparatively larger, the period effect also represented an important factor influencing IHD mortality trends in China given its close association with trends in crude IHD mortality in urban and rural both populations. Similar results have been reported from studies using APC analysis to investigate secular trends in other chronic diseases in China [37,41]. One factor driving the increasing influence of the period effect on IHD mortality may be rising levels of air pollution, identified as the most significant environmental risk factor globally [42] and a major determinant of IHD morbidity and mortality [43] in China over recent decades. It is estimated that 9.4% of IHD mortality worldwide is attributable to exposure to anthropogenic PM2.5 alone [44], and recent studies have reported significant associations between ambient PM2.5 and PM10 (particle less than 10 mm in aerodynamic diameter) concentrations and IHD mortality among Chinese citizens [45,46,47]. Conversely, the sharp decrease in the strength of the period effect in the urban population from 1998 to 2003 may have been the result of changes in reporting following the move from ICD-9 to ICD-10 codes in 2002. The same pattern was not observed in rural populations over the same period, however. After adjustment of the data in ICD-9 format collected prior to 2002, the abnormal V-shape trend of period effects on urban IHD mortality disappeared.
The primary limitation of this study is that its results cannot describe the causal mechanisms through which age, period, and cohort influence mortality. Instead, APC analysis provides an exploratory tool to describe population-level patterns in mortality. By extension, to avoid succumbing to the ecological fallacy, it should be noted that our findings based on population-level data do not necessarily hold for individuals. Further analyses employing individual-level data are therefore required to identify these causal mechanisms. Another important limitation is the ICD change implemented with ICD-10 in 2002, which may have affected the mortality trends. However, the sensitivity analysis based on adjusted data showed that the impact of change in ICD on the APC model results was small, except for the trend of period effects in urban population. Thus, our interpretation of the results and the main conclusions were not influenced by the change in ICD.

5. Conclusions

Our findings indicate that China’s rapid population aging in recent years has played a critical role in driving the rising trend in IHD mortality in both urban and rural populations. Period effects, which may reflect the population-wide increase in exposure to environmental risk factors such as outdoor air pollution, also represent a major factor influencing the trend in mortality. Although lifestyle risk factors resulting from changing diets and physical inactivity are highly prevalent among younger generations, their long-term effects may not yet have manifested in a notable cohort effect on IHD mortality. More evidence, however, is required to identify the factors driving the upward trend in IHD mortality in the world’s most populous country and elucidate their causal mechanisms.
Although population aging is inevitable, there is scope for policymakers in China and other countries confronting the epidemiologic transition to reduce the disease burden and mortality rates due to IHD. Possible avenues for intervention could include improving social protection and healthcare provision for elderly populations, extending public health insurance to cover the spending of primary healthcare in the community, where most management of IHD risk factors takes place, undertaking measures to limit exposure to air pollution and other environmental risk factors, and implementing public education programs to reduce lifestyle risk factors.

Supplementary Materials

The following are available online at www.mdpi.com/1660-4601/14/1/50/s1, Figure S1: Adjusted ischemic heart disease (IHD) mortality rates trend in urban and rural China, 1987–2013, Figure S2: Age-period-cohort effects on IHD mortality in China (adjusted results), Figure S3: (a) Comparability between adjusted and unadjusted results of age effects on IHD mortality; (b) Comparability between adjusted and unadjusted results of period effects on IHD mortality; (c) Comparability between adjusted and unadjusted results of cohort effects on IHD mortality, Table S1: Intrinsic estimates for adjusted ischemic heart disease (IHD) mortality rates in urban and rural Chinese population.

Acknowledgments

This study was supported by National Natural Science Foundation of China (71303012, 71503196, 71573192), the China Postdoctoral Science Foundation (2015M580862, 2016T90935), and the Shaanxi Provincial Social Science Fund (2015R009). The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.

Author Contributions

Jie Chang, Yang Sun, and Boyang Li participated in the conception and design of the study; Jie Chang, Yang Sun, and Jingjing Li participated in the data analysis; Jie Chang and Yang Sun did the interpretation of the results; Jie Chang and Yang Sun did the analysis of the literature, and wrote the article. All authors read and approved the final manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Lozano, R.; Naghavi, M.; Foreman, K.; Lim, S.; Shibuya, K.; Aboyans, V.; Abraham, J.; Adair, T.; Aggarwal, R.; Ahn, S.Y.; et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380, 2095–2128. [Google Scholar] [CrossRef]
  2. Moran, A.E.; Forouzanfar, M.H.; Roth, G.A.; Mensah, G.A.; Ezzati, M.; Flaxman, A.; Murray, C.J.; Naghavi, M. The global burden of ischemic heart disease in 1990 and 2010: The Global Burden of Disease 2010 study. Circulation 2014, 129, 1493–1501. [Google Scholar] [CrossRef] [PubMed]
  3. Shepard, D.; VanderZanden, A.; Moran, A.; Naghavi, M.; Murray, C.; Roth, G. Ischemic Heart Disease Worldwide, 1990 to 2013: Estimates From the Global Burden of Disease Study 2013. Circ. Cardiovasc. Qual. Outcomes 2015, 8, 455–456. [Google Scholar] [CrossRef] [PubMed]
  4. Forouzanfar, M.H.; Moran, A.E.; Flaxman, A.D.; Roth, G.; Mensah, G.A.; Ezzati, M.; Naghavi, M.; Murray, C.J. Assessing the global burden of ischemic heart disease, part 2: Analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Glob. Heart 2012, 7, 331–342. [Google Scholar] [CrossRef] [PubMed]
  5. Moran, A.E.; Oliver, J.T.; Mirzaie, M.; Forouzanfar, M.H.; Chilov, M.; Anderson, L.; Morrison, J.L.; Khan, A.; Zhang, N.; Haynes, N.; et al. Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010. Glob. Heart 2012, 7, 315–329. [Google Scholar] [CrossRef] [PubMed]
  6. Hartley, A.; Marshall, D.C.; Salciccioli, J.D.; Sikkel, M.B.; Maruthappu, M.; Shalhoub, J. Trends in Mortality From Ischemic Heart Disease and Cerebrovascular Disease in Europe: 1980 to 2009. Circulation 2016, 133, 1916–1926. [Google Scholar] [CrossRef] [PubMed]
  7. Yusuf, S.; McKee, M. Documenting the global burden of cardiovascular disease: A major achievement but still a work in progress. Circulation 2014, 129, 1459–1462. [Google Scholar] [CrossRef] [PubMed]
  8. Gaziano, T.A.; Bitton, A.; Anand, S.; Abrahams-Gessel, S.; Murphy, A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr. Probl. Cardiol. 2010, 35, 72–115. [Google Scholar] [CrossRef] [PubMed]
  9. Nowbar, A.N.; Howard, J.P.; Finegold, J.A.; Asaria, P.; Francis, D.P. 2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: Statistics from World Health Organisation and United Nations. Int. J. Cardiol. 2014, 174, 293–298. [Google Scholar] [CrossRef] [PubMed]
  10. World Health Organization; World Heart Federation; World Stroke Organization. Global Atlas on Cardiovascular Disease Prevention and Control: Policies, Strategies and Interventions. 2011. Available online: http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/ (accessed on 12 September 2016).
  11. Barquera, S.; Pedroza-Tobías, A.; Medina, C.; Hernández-Barrera, L.; Bibbins-Domingo, K.; Lozano, R.; Moran, A.E. Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease. Arch. Med. Res. 2015, 46, 328–338. [Google Scholar] [CrossRef] [PubMed]
  12. Glenn, N.D. Age, Period, and Cohort Effects. In Encyclopedia of Social Measurement; Kempf-Leonard, K., Ed.; Elsevier: Amsterdam, The Netherlands, 2005; pp. 27–32. [Google Scholar]
  13. Yang, Y. Trends in U.S. adult chronic disease mortality, 1960–1999: Age, period, and cohort variations. Demography 2008, 45, 387–416. [Google Scholar] [CrossRef]
  14. Yu, I.T.; Li, W.; Wong, T.W. Effects of age, period and cohort on acute myocardial infarction mortality in Hong Kong. Int. J. Cardiol. 2004, 97, 63–68. [Google Scholar] [CrossRef] [PubMed]
  15. Yang, G.; Kong, L.; Zhao, W.; Wan, X.; Zhai, Y.; Chen, L.C.; Koplan, J.P. Emergence of chronic non-communicable diseases in China. Lancet 2008, 372, 1697–1705. [Google Scholar] [CrossRef]
  16. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388, 1459–1544. [Google Scholar]
  17. Ocaña-Riola, R.; Mayoral-Cortés, J.M.; Fernández-Ajuria, A.; Sánchez-Cantalejo, C.; Martín-Olmedo, P.; Blanco-Reina, E. Age, Period, and Cohort Effects on Mortality From Ischemic Heart Disease in Southern Spain. Rev. Esp. Cardiol. 2015, 68, 373–381. [Google Scholar] [CrossRef] [PubMed]
  18. Ma, E.; Iso, H.; Takahashi, H.; Yamagishi, K.; Tanigawa, T. Age-Period-Cohort analysis of mortality due to ischemic heart disease in Japan, 1955 to 2000. Circ. J. 2008, 72, 966–972. [Google Scholar] [CrossRef] [PubMed]
  19. Gero, K.; Eshak, E.S.; Ma, E.; Takahashi, H.; Noda, H.; Iso, H. Health Disparities in Ischaemic Heart Disease Mortality in Hungary From 1970 to 2010: An Age-Period-Cohort Analysis. J. Epidemiol. 2015, 25, 399–406. [Google Scholar] [CrossRef] [PubMed]
  20. Peltonen, M.; Asplund, K. Age-period-cohort effects on ischaemic heart disease mortality in Sweden from 1969 to 1993, and forecasts up to 2003. Eur. Heart J. 1997, 18, 1307–1312. [Google Scholar] [CrossRef] [PubMed]
  21. Chung, R.Y.; Schooling, C.M.; Cowling, B.J.; Leung, G.M. How does socioeconomic development affect risk of mortality? An age-period-cohort analysis from a recently transitioned population in China. Am. J. Epidemiol. 2010, 171, 345–356. [Google Scholar] [CrossRef] [PubMed]
  22. Lee, H.A.; Park, H. Trends in ischemic heart disease mortality in Korea, 1985–2009: An age-period-cohort analysis. J. Prev. Med. Public Health 2012, 45, 323–328. [Google Scholar] [CrossRef] [PubMed]
  23. Moran, A.; Zhao, D.; Gu, D.; Coxson, P.; Chen, C.-S.; Cheng, J.; Liu, J.; He, J.; Goldman, L. The future impact of population growth and aging on coronary heart disease in China: Projections from the Coronary Heart Disease Policy Model-China. BMC Public Health 2008, 8, 394. [Google Scholar] [CrossRef] [PubMed]
  24. Moran, A.; Gu, D.; Zhao, D.; Coxson, P.; Wang, Y.C.; Chen, C.-S.; Liu, J.; Cheng, J.; Bibbins-Domingo, K.; Shen, Y.M. Future cardiovascular disease in China: Markov model and risk factor scenario projections from the coronary heart disease policy model-China. Circ. Cardiovasc. Qual. Outcomes 2010, 3, 243–252. [Google Scholar] [CrossRef] [PubMed]
  25. Critchley, J.; Liu, J.; Zhao, D.; Wei, W.; Capewell, S. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 2004, 110, 1236–1244. [Google Scholar] [CrossRef] [PubMed]
  26. Mason, K.O.; Mason, W.M.; Winsborough, H.H.; Poole, W.K. Some Methodological Issues in Cohort Analysis of Archival Data. Am. Sociol. Rev. 1973, 38, 242–258. [Google Scholar] [CrossRef]
  27. Smith, H.L. Advances in Age-Period-Cohort Analysis. Sociol. Method Res. 2008, 36, 287–296. [Google Scholar] [CrossRef]
  28. Yang, Y.; Schulhofer-Wohl, S.; Fu, W.J.; Land, K.C. The intrinsic estimator for age-period-cohort analysis: What it is and how to use it. Am. J. Sociol. 2008, 113, 1697–1736. [Google Scholar] [CrossRef]
  29. Phillips, J.A. A changing epidemiology of suicide? The influence of birth cohorts on suicide rates in the United States. Soc. Sci. Med. 2014, 114, 151–160. [Google Scholar] [CrossRef] [PubMed]
  30. Chen, X.; Lin, F.; Stanton, B.; Zhang, X. APC modeling of smoking prevalence among US adolescents and young adults. Am. J. Health Behav. 2011, 35, 416–427. [Google Scholar] [CrossRef] [PubMed]
  31. Jankowski, P.; Czarnecka, D.; Wolfshaut-Wolak, R.; Łysek, R.; Łukaszewska, A.; Surowiec, S.; Loster, M.; Bogacki, P.; Bryniarska-Mirek, E.; Grodecki, J.; et al. Age, sex, and secondary prevention of ischaemic heart disease in everyday practice. Kardiol. Pol. 2013, 71, 1251–1259. [Google Scholar] [CrossRef] [PubMed]
  32. Population Census Office under the State Council (PCO). Tabulation on the 2000 Population Census of the People’s Republic of China; China Statistics Press: Beijing, China, 2002. [Google Scholar]
  33. Population Census Office under the State Council (PCO). Tabulation on the 2010 Population Census of the People’s Republic of China; China Statistics Press: Beijing, China, 2012. [Google Scholar]
  34. Cheng, J.; Zhao, D.; Zeng, Z.; Critchley, J.A.; Liu, J.; Wang, W.; Sun, J.; Capewell, S. The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999–2010. BMC Public Health 2009, 9, 30. [Google Scholar] [CrossRef] [PubMed]
  35. WHO. Database: Outdoor Air Pollution in Cities. Available online: http://www.who.int/phe/health_topics/outdoorair/databases/cities-2011/en/ (accessed on 6 December 2016).
  36. Fang, D.; Wang, Q.; Li, H.; Yu, Y.; Lu, Y.; Qian, X. Mortality effects assessment of ambient PM2.5 pollution in the 74 leading cities of China. Sci. Total Environ. 2016, 569–570, 1545–1552. [Google Scholar] [CrossRef] [PubMed]
  37. Wang, Z.; Bao, J.; Yu, C.; Wang, J.; Li, C. Secular Trends of Breast Cancer in China, South Korea, Japan and the United States: Application of the Age-Period-Cohort Analysis. Int. J. Environ. Res. Public Health 2015, 12, 15409–15418. [Google Scholar] [CrossRef] [PubMed]
  38. Wang, Z.; Yu, C.; Wang, J.; Bao, J.; Gao, X.; Xiang, H. Age-period-cohort analysis of suicide mortality by gender among white and black Americans, 1983–2012. Int. J. Equity Health 2016, 15, 107. [Google Scholar] [CrossRef] [PubMed]
  39. Chinese Center of Disease Control and Prevention. Global Adults Tobacco Survey (GATS) China 2010 Country Report. 2011. Available online: http://www.who.int/tobacco/surveillance/survey/gats/en_gats_china_report.pdf?ua=1 (accessed on 14 September 2016).
  40. Yang, G.; Wang, Y.; Wu, Y.; Yang, J.; Wan, X. The road to effective tobacco control in China. Lancet 2015, 385, 1019–1028. [Google Scholar] [CrossRef]
  41. Wang, J.; Bai, Z.; Wang, Z.; Yu, C. Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis. Int. J. Environ. Res. Public Health 2016, 13, 1148. [Google Scholar] [CrossRef] [PubMed]
  42. Burnett, R.T.; Pope, C.A., 3rd; Ezzati, M.; Olives, C.; Lim, S.S.; Mehta, S.; Shin, H.H.; Singh, G.; Hubbell, B.; Brauer, M.; et al. An integrated risk function for estimating the Global Burden of Disease attributable to ambient fine particulate matter exposure. Environ. Health Perspect. 2014, 122, 397–403. [Google Scholar] [CrossRef] [PubMed]
  43. World Health Organization. Ambient (Outdoor) Air Quality and Health. Fact Sheet No. 313. 2014. Available online: http://www.who.int/mediacentre/factsheets/fs313/en/ (accessed on 15 September 2016).
  44. Evans, J.; van Donkelaar, A.; Martin, R.V.; Burnett, R.; Rainham, D.G.; Birkett, N.J.; Krewski, D. Estimates of global mortality attributable to particulate air pollution using satellite imagery. Environ. Res. 2013, 120, 33–42. [Google Scholar] [CrossRef] [PubMed]
  45. Xie, W.; Li, G.; Zhao, D.; Xie, X.; Wei, Z.; Wang, W.; Wang, M.; Li, G.; Liu, W.; Sun, J.; et al. Relationship between fine particulate air pollution and is chaemic heart disease morbidity and mortality. Heart 2015, 101, 257–263. [Google Scholar] [CrossRef] [PubMed]
  46. Xu, M.; Guo, Y.; Zhang, Y.; Westerdahl, D.; Mo, Y.; Liang, F.; Pan, X. Spatiotemporal analysis of particulate air pollution and ischemic heart disease mortality in Beijing, China. Environ. Health 2014, 13, 109. [Google Scholar] [CrossRef] [PubMed]
  47. Li, G.; Zeng, Q.; Pan, X. Disease burden of ischaemic heart disease from short-term outdoor air pollution exposure in Tianjin, 2002–2006. Eur. J. Prev. Cardiol. 2016, 23, 1774–1782. [Google Scholar] [CrossRef] [PubMed]
Ijerph 14 00050 g001 550
Figure 1. Ischemic heart disease (IHD) mortality rates trend in urban and rural China, 1987–2013.
Figure 1. Ischemic heart disease (IHD) mortality rates trend in urban and rural China, 1987–2013.
Ijerph 14 00050 g001
Ijerph 14 00050 g002 550
Figure 2. Age-specific IHD mortality in urban and rural China, by time period.
Figure 2. Age-specific IHD mortality in urban and rural China, by time period.
Ijerph 14 00050 g002
Ijerph 14 00050 g003 550
Figure 3. Period-specific IHD mortality rates in urban and rural China, by age group.
Figure 3. Period-specific IHD mortality rates in urban and rural China, by age group.
Ijerph 14 00050 g003
Ijerph 14 00050 g004 550
Figure 4. Cohort-specific IHD mortality rates in urban and rural China, by age group.
Figure 4. Cohort-specific IHD mortality rates in urban and rural China, by age group.
Ijerph 14 00050 g004
Ijerph 14 00050 g005 550
Figure 5. Age-period-cohort effects on IHD mortality in China.
Figure 5. Age-period-cohort effects on IHD mortality in China.
Ijerph 14 00050 g005
Table
Table 1. Goodness-of-fit statistics for age-period-cohort log linear models of China ischemic heart disease (IHD) mortality rates between 1987 and 2013.
Table 1. Goodness-of-fit statistics for age-period-cohort log linear models of China ischemic heart disease (IHD) mortality rates between 1987 and 2013.
AgePeriodCohortAge-PeriodAge-CohortPeriod-CohortAge-Period-Cohort
Urban population
Deviance19,896.832,899,129.19648,370.437322.3114,118.803152.121653.67
AIC265.7237,178.789349.67104.64192.0851.3032.37
BIC19,613.652,898,816648,1097060.9113,909.682912.501461.98
DOF65726060485544
Rural population
Deviance230,787.785,216,118.222,004,389.5428,468.2647,406.3723,521.5814,191.24
AIC2970.2366,884.5425,708.84376.51619.62313.22193.88
BIC230,504.605,215,8052,004,12828,206.8547,197.2423,281.9613,999.55
DOF65726060485544
AIC = Akaike’s information criterion; BIC = Bayesian information criterion; DOF = Degree of freedom. The smaller the AIC and BIC, the better the model fit.
Table
Table 2. Intrinsic estimates for IHD mortality rates in urban and rural Chinese population.
Table 2. Intrinsic estimates for IHD mortality rates in urban and rural Chinese population.
Urban PopulationRural Population
Coeff.S.E.Coeff.S.E.
Intercept−7.97 *0.02−8.19 *0.04
Age (Year)
20–24−2.92 *0.15−2.48 *0.27
25–29−2.51 *0.11−2.15 *0.20
30–34−1.82 *0.08−1.46 *0.15
35–39−1.36 *0.07−1.20 *0.12
40–44−0.72 *0.05−0.63 *0.10
45–49−0.34 *0.05−0.450.09
50–540.14 *0.040.08 *0.07
55–590.48 *0.030.29 *0.06
60–640.95 *0.030.70 *0.05
65–691.42 *0.021.11 *0.05
70–741.84 *0.021.62 *0.04
75–792.21 *0.022.02 *0.05
80–842.63 *0.032.56 *0.05
Period (Year)
1988−0.54 *0.03−0.67 *0.06
1993−0.20 *0.02−0.48 *0.04
19980.11 *0.02−0.10 *0.03
2003−0.09 *0.020.17 *0.03
20080.19 *0.020.21 *0.03
20130.52 *0.020.87 *0.04
Cohort (Year)
1904–19081.52 *0.060.99 *0.14
1909–19131.28 *0.040.89 *0.09
1914–19181.08 *0.030.75 *0.07
1919–19230.89 *0.030.71 *0.06
1924–19280.790.020.80 *0.05
1929–19330.62 *0.020.65 *0.04
1934–19380.34 *0.030.470.05
1939–19430.01 *0.030.270.06
1944–1948−0.18 *0.040.16 *0.07
1949–1953−0.26 *0.050.03 *0.08
1954–1958−0.40 *0.05−0.19 *0.10
1959–1963−0.45 *0.06−0.41 *0.11
1964–1968−0.60 *0.07−0.41 *0.12
1969–1973−0.64 *0.08−0.67 *0.14
1974–1978−0.91 *0.10−0.92 *0.18
1979–1983−0.97 *0.13−1.09 *0.26
1984–1988−0.98 *0.17−0.83 *0.31
1989–1993−1.15 *0.29−1.20 *0.51
* p < 0.05; exponentiated coefficients interpreted as odds ratios; Coeff. = coefficient; S.E. = standard error of the coefficients.

Share and Cite

MDPI and ACS Style

Chang, J.; Li, B.; Li, J.; Sun, Y. The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China. Int. J. Environ. Res. Public Health 2017, 14, 50. https://doi.org/10.3390/ijerph14010050

AMA Style

Chang J, Li B, Li J, Sun Y. The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China. International Journal of Environmental Research and Public Health. 2017; 14(1):50. https://doi.org/10.3390/ijerph14010050

Chicago/Turabian Style

Chang, Jie, Boyang Li, Jingjing Li, and Yang Sun. 2017. "The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China" International Journal of Environmental Research and Public Health 14, no. 1: 50. https://doi.org/10.3390/ijerph14010050

APA Style

Chang, J., Li, B., Li, J., & Sun, Y. (2017). The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China. International Journal of Environmental Research and Public Health, 14(1), 50. https://doi.org/10.3390/ijerph14010050

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop